DataArt
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
Upcoming event
Related Content
Research & Development
How AI will disrupt drug development
In the last 4–6 years, companies have been experimenting with new approaches that utilise the latest in artificial intelligence (AI) and machine learning technologies to identify new molecules and validate new drugs faster and more efficiently. Egor Kobelev, VP of Healthcare and Life Sciences at DataArt, examines some of the ways these breakthroughs are transforming drug discovery